🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Shintaro Kanda

Shinshu University

ORCID: 0000-0001-7864-3928

Also affiliated with Shinshu University Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 2 papers. Top paper: “Sequential Use of Anaplastic Lymphoma Kinase Inhibitors in Japanese Patients With ALK-Rearranged Non–Small-Cell Lung Cancer: A Retrospective Analysis”.

Sequential Use of Anaplastic Lymphoma Kinase Inhibitors in Japanese Patients With ALK-Rearranged Non–Small-Cell Lung Cancer: A Retrospective Analysis

Clinical Lung Cancer(2017)10.1016/j.cllc.2016.11.015
N/A
0.888DataRank · unranked
18 citations

Yutaka Fujiwara, Kota Itahashi, Shinsuke Kitahara, Yasushi Goto, Hidehito Horinouchi +6 more

Effect of sequential chemoradiotherapy in patients with limited-disease small-cell lung cancer who were ineligible for concurrent therapy: a retrospective study at two institutions

Japanese Journal of Clinical Oncology(2018)10.1093/jjco/hyx153
N/A
0.517DataRank · unranked
7 citations

Shintaro Kanda, Hitomi Okuma, Yasushi Goto, Hidehito Horinouchi, Yutaka Fujiwara +7 more